Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
Unveiling the Future of Personalised Sleep Medicine
Nurturing Trust in Healthcare: Embracing Generative AI
Precision Medicine Competency Framework for the Medical Technology and Pharma...
Health equity insights for National Cancer Survivors Day
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Patient Empowerment in Their Pockets: AI Chatbots in Healthcare
Improving Patient Safety Culture in African Health Facilities: A Systematic R...
Use of AI in Genetic Diagnosis: Identifying Rare Diseases
« Previous
1
…
7
8
9
10
11
…
17
Next »